The effects of Concerta [methylphenidate] on the brain structures of children with attention deficit hyperactivity disorder, measured by three-dimensional magnetic resonance (3D-MR) volumetry and diffusion-tensor imaging (DTI)

Trial Profile

The effects of Concerta [methylphenidate] on the brain structures of children with attention deficit hyperactivity disorder, measured by three-dimensional magnetic resonance (3D-MR) volumetry and diffusion-tensor imaging (DTI)

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2013

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Biomarker; Pharmacodynamics
  • Acronyms COSA
  • Sponsors Janssen
  • Most Recent Events

    • 31 Dec 2012 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials.
    • 11 Dec 2009 Planned end date changed from 31 Dec 2008 to 31 Dec 2012 as reported by ISRCTN: Current Controlled Trials.
    • 11 Dec 2009 Planned number of patients changed from 30 to 80 as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top